Computational modeling of retinal hypoxia and photoreceptor degeneration in patients with age-related macular degeneration.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
24
10
2018
accepted:
16
04
2019
entrez:
12
6
2019
pubmed:
12
6
2019
medline:
6
2
2020
Statut:
epublish
Résumé
Although drusen have long been acknowledged as a primary hallmark of dry age-related macular degeneration (AMD) their role in the disease remains unclear. We hypothesize that drusen accumulation increases the barrier to metabolite transport ultimately resulting in photoreceptor cell death. To investigate this hypothesis, a computational model was developed to evaluate steady-state oxygen distribution in the retina. Optical coherence tomography images from fifteen AMD patients and six control subjects were segmented and translated into 3D in silico representations of retinal morphology. A finite element model was then used to determine the steady-state oxygen distribution throughout the retina for both generic and patient-specific retinal morphology. Oxygen levels were compared to the change in retinal thickness at a later time point to observe possible correlations. The generic finite element model of oxygen concentration in the retina agreed closely with both experimental measurements from literature and clinical observations, including the minimal pathological drusen size identified by AREDS (64 μm). Modeling oxygen distribution in the outer retina of AMD patients showed a substantially stronger correlation between hypoxia and future retinal thinning (Pearson correlation coefficient, r = 0.2162) than between drusen height and retinal thinning (r = 0.0303) indicating the potential value of this physiology-based approach. This study presents proof-of-concept for the potential utility of finite element modeling in evaluating retinal health and also suggests a potential link between transport and AMD pathogenesis. This strategy may prove useful as a prognostic tool for predicting the clinical risk of AMD progression.
Identifiants
pubmed: 31185022
doi: 10.1371/journal.pone.0216215
pii: PONE-D-18-30794
pmc: PMC6559637
doi:
Substances chimiques
Oxygen
S88TT14065
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0216215Subventions
Organisme : NEI NIH HHS
ID : P30 EY005722
Pays : United States
Organisme : NIH HHS
ID : DP2 OD006649
Pays : United States
Organisme : NEI NIH HHS
ID : K12 EY016335
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY027739
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY003790
Pays : United States
Déclaration de conflit d'intérêts
K.M., M.S.G., and L.A.K. hold a patent (US9986905B2) entitled “Predicting retinal degeneration based on three-dimensional modeling of oxygen concentration.” This patent outlines the technique used here to assess steady-state retinal oxygen levels in the retina using OCT images and finite element analysis. S.F. holds several patents (US9299155B2, US8811745B2, US20110182517A1, and US20120184846A1), which relate to the segmentation method used to identify retinal layers in OCT images. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Références
J Cataract Refract Surg. 1987 Mar;13(2):136-40
pubmed: 3572768
Am J Physiol Heart Circ Physiol. 2007 Sep;293(3):H1696-704
pubmed: 17557923
J Gen Physiol. 1986 Oct;88(4):521-42
pubmed: 3783124
Opt Express. 2010 Aug 30;18(18):19413-28
pubmed: 20940837
Arch Ophthalmol. 2005 Nov;123(11):1570-4
pubmed: 16286620
Light Sci Appl. 2015 Sep;4(9):
pubmed: 26658555
Med Hypotheses. 2012 Apr;78(4):423-7
pubmed: 22284635
Prog Retin Eye Res. 2016 Jul;53:48-69
pubmed: 27063291
J Math Biol. 2016 Jul;73(1):1-38
pubmed: 26370669
Am J Ophthalmol. 2017 Feb;174:42-55
pubmed: 27794427
Invest Ophthalmol Vis Sci. 2011 Mar 18;52(3):1486-92
pubmed: 21071737
Adv Exp Med Biol. 1990;277:127-36
pubmed: 2096618
Physiol Meas. 2004 Dec;25(6):1523-32
pubmed: 15712729
Arch Ophthalmol. 1976 May;94(5):755-7
pubmed: 1267653
J Gen Physiol. 1992 Feb;99(2):177-97
pubmed: 1613482
Invest Ophthalmol Vis Sci. 2004 Feb;45(2):617-24
pubmed: 14744906
Ophthalmology. 2005 May;112(5):787-98
pubmed: 15878058
Eye Brain. 2010;2:99-116
pubmed: 23226947
Ophthalmology. 2009 Mar;116(3):488-496.e2
pubmed: 19167082
Exp Eye Res. 2005 Jun;80(6):745-51
pubmed: 15939030
Trans Am Ophthalmol Soc. 1937;35:262-94
pubmed: 16693123
Prog Retin Eye Res. 2017 May;58:115-151
pubmed: 28109737
Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1839-46
pubmed: 27082298
Retina. 2019 Aug;39(8):1527-1540
pubmed: 29781974
Am J Ophthalmol. 2013 Aug;156(2):304-11
pubmed: 23659972
Arch Ophthalmol. 2003 Apr;121(4):547-57
pubmed: 12695252
Ann Biomed Eng. 1990;18(1):19-36
pubmed: 2306030
Arch Ophthalmol. 1964 Dec;72:792-5
pubmed: 14205438
Invest Ophthalmol Vis Sci. 1993 Mar;34(3):516-21
pubmed: 8449672
Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6591-604
pubmed: 26501235
Undersea Hyperb Med. 2010 Mar-Apr;37(2):101-5
pubmed: 20462142
Acta Physiol Scand. 1972 Feb;84(2):261-74
pubmed: 5015191
Prog Retin Eye Res. 2011 Jan;30(1):72-80
pubmed: 20951826
Ophthalmic Epidemiol. 2004 Apr;11(2):67-115
pubmed: 15255026
Invest Ophthalmol Vis Sci. 2001 Nov;42(12):2970-5
pubmed: 11687544
Clin Exp Optom. 2005 Sep;88(5):269-81
pubmed: 16255686
Curr Biol. 2008 Dec 23;18(24):1917-21
pubmed: 19084410
Biomed Res Int. 2014;2014:768026
pubmed: 24707498
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3714-22
pubmed: 27415789
Brain Res Brain Res Rev. 2000 Nov;34(1-2):42-68
pubmed: 11086186
Workplace Health Saf. 2014 Aug;62(8):352
pubmed: 25093372
Eur J Pharm Sci. 2008 Oct 2;35(3):175-82
pubmed: 18662774
Am J Ophthalmol. 2017 Aug;180:55-63
pubmed: 28579063
Invest Ophthalmol Vis Sci. 1995 Jun;36(7):1290-7
pubmed: 7775106
Retina. 2014 Sep;34(9):1854-60
pubmed: 24732694
Physiol Rev. 2005 Jul;85(3):845-81
pubmed: 15987797
Invest Ophthalmol Vis Sci. 2003 Feb;44(2):745-50
pubmed: 12556408
Br J Ophthalmol. 2013 Aug;97(8):1020-3
pubmed: 23740965
Graefes Arch Clin Exp Ophthalmol. 1990;228(2):143-50
pubmed: 2338252
Graefes Arch Clin Exp Ophthalmol. 2017 Aug;255(8):1551-1558
pubmed: 28534244